Protein Official symbol | AMY2A |
Aliases | AMY2A |
Chromosomal Location | 1 |
Length | 511 |
Uniprot ID | P04746 |
EC number | 3.2.1.1 |
Protein family Information(Pfam) | PF00128;PF02806; |
PDB id | 1B2Y;1BSI;1CPU;1HNY;1KB3;1KBB;1KBK;1KGU;1KGW;1KGX;1U2Y;1U30;1U33;1XCW;1XCX;1XD0;1XD1;1XGZ;1XH0;1XH1;1XH2;2CPU;2QMK;2QV4;3BAI;3BAJ;3BAK;3BAW;3BAX;3BAY;3CPU;3IJ7;3IJ8;3IJ9;3OLD;3OLE;3OLG;3OLI;4GQQ;4GQR;4W93;4X9Y;5E0F;5EMY;5KEZ;5TD4;5U3A;5VA9;6OBX;6OCN; |
InterPro ID | IPR006048;IPR031319;IPR006046;IPR006047;IPR013780;IPR017853; |
dbSNP | None |
Protein 1 | Protein 2 | Combine Score |
---|---|---|
AMY2A | LOC93432 | 0.98 |
AMY2A | MGAM | 0.971 |
AMY2A | SI | 0.971 |
LOC93432 | GBE1 | 0.951 |
MGAM | GBE1 | 0.946 |
AMY2A | GBE1 | 0.932 |
GANC | SI | 0.924 |
LOC93432 | GANC | 0.9209999999999999 |
MGAM | GANC | 0.9179999999999999 |
AMY2A | GANC | 0.909 |
MGAM | SI | 0.907 |
LOC93432 | SI | 0.903 |
LOC93432 | MGAM | 0.9 |
# | 279 (AMY2A) | 8972 (MGAM) | 2595 (GANC) | 6476 (SI) | 2632 (GBE1) |
---|---|---|---|---|---|
279 (AMY2A) | 1.00 | 0.36 | 0.48 | 0.31 | 0.30 |
8972 (MGAM) | 0.36 | 1.00 | 1.00 | 0.77 | 0.36 |
2595 (GANC) | 0.48 | 1.00 | 1.00 | 1.00 | 0.15 |
6476 (SI) | 0.31 | 0.77 | 1.00 | 1.00 | 0.15 |
2632 (GBE1) | 0.30 | 0.36 | 0.15 | 0.15 | 1.00 |
Protein Official symbol | Source Organism | Tissue of Expression | Level of hypoxia | Altitude | Duration of experiment | Level of expression | Fold change | Experiment details | geographical location | ethnicity of the patients | Control group | Control (Fold change) | Reference (PMID) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
AMY2A | Human | Saliva | - | 4175 m | 7 day | downregulated | 28.07 | 2-DE | Himalayas | Indians | 20.43 | Individuals residing at sea level | 30219637 |
TF | TF Entrez | Gene | Gene Entrez | Type | PMID | Database |
---|
miRTarBase ID | miRNA | Species (miRNA) | Protein Official Symbol | Human Entrez ID | Species (Target Gene) | Experiments | Support Type | References (PMID) |
---|
ID | GO ID | GO Term | GO Type |
---|---|---|---|
279 | GO:0004556 | ribonuclease activity | GOTERM_MF_DIRECT |
279 | GO:0005615 | extracellular space | GOTERM_CC_DIRECT |
279 | GO:0044245 | polysaccharide digestion | GOTERM_BP_DIRECT |
279 | GO:0043169 | ATP-dependent 3'-5' DNA helicase activity | GOTERM_MF_DIRECT |
279 | GO:0003824 | antigen binding | GOTERM_MF_DIRECT |
279 | GO:0016052 | carbohydrate catabolic process | GOTERM_BP_DIRECT |
279 | GO:0005576 | extracellular region | GOTERM_CC_DIRECT |
279 | GO:0031404 | small GTPase binding | GOTERM_MF_DIRECT |
279 | GO:0005975 | carbohydrate metabolic process | GOTERM_BP_DIRECT |
279 | GO:0005509 | calcium ion binding | GOTERM_MF_DIRECT |
279 | GO:0070062 | extracellular exosome | GOTERM_CC_DIRECT |
Protein Official Symbol | Human Entrez ID | Disease Name | Disease Id | Disease Semantic Type | Semantic score | DSI | DPI | Disease Type |
---|
Protein Official Symbol | Human Entrez ID | drug_claim_primary_name | drug_name | drug_chembl_id | interaction_types |
---|---|---|---|---|---|
AMY2A | 279 | ACARBOSE | ACARBOSE | CHEMBL1566 | None |
AMY2A | 279 | ACARBOSE | ACARBOSE | CHEMBL1566 | None |
AMY2A | 279 | ACARBOSE | ACARBOSE | CHEMBL1566 | inhibitor |